{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:14:12Z","timestamp":1794258852596,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873548"],"award-info":[{"award-number":["81873548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100583"],"award-info":[{"award-number":["82100583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanjing Medical University Fan Daiming Research Funds for Holistic Integrative Medicine","award":["2020-3"],"award-info":[{"award-number":["2020-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04353-y","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:36:26Z","timestamp":1756740986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Fecal microbiota transplantation improves bile acid malabsorption in patients with inflammatory bowel disease: results of microbiota and metabolites from two cohort studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Gaochen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bota","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"7","key":"4353_CR1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.cell.2024.02.019","volume":"187","author":"I Mohanty","year":"2024","unstructured":"Mohanty I, Mannochio-Russo H, Schweer JV, El Abiead Y, Bittremieux W, Xing S, et al. The underappreciated diversity of bile acid modifications. Cell. 2024;187(7):1801-1818.e20.","journal-title":"Cell"},{"issue":"4","key":"4353_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S2468-1253(22)00401-0","volume":"8","author":"C Borup","year":"2023","unstructured":"Borup C, Vinter-Jensen L, J\u00f8rgensen SPG, Wildt S, Graff J, Gregersen T, et al. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial. Lancet Gastroenterol Hepatol. 2023;8(4):321\u201331.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"4353_CR3","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1136\/gutjnl-2022-329213","volume":"72","author":"M Lewinska","year":"2023","unstructured":"Lewinska M, K\u00e5rhus ML, Ellegaard AG, Romero-G\u00f3mez M, Macias RIR, Andersen JB, et al. Serum lipidome unravels a diagnostic potential in bile acid diarrhoea. Gut. 2023;72(9):1698\u2013708.","journal-title":"Gut"},{"issue":"8","key":"4353_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/gut.12.8.632","volume":"12","author":"TA Miettinen","year":"1971","unstructured":"Miettinen TA. The role of bile salts in diarrhoea of patients with ulcerative colitis. Gut. 1971;12(8):632\u20135.","journal-title":"Gut"},{"issue":"3","key":"4353_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0300-5089(21)00739-2","volume":"15","author":"H Fromm","year":"1986","unstructured":"Fromm H, Malavolti M. Bile acid-induced diarrhoea. Clin Gastroenterol. 1986;15(3):567\u201382.","journal-title":"Clin Gastroenterol"},{"issue":"1","key":"4353_CR6","doi-asserted-by":"publisher","first-page":"2323231","DOI":"10.1080\/19490976.2024.2323231","volume":"16","author":"W Chen","year":"2024","unstructured":"Chen W, Wang D, Deng X, Zhang H, Dong D, Su T, et al. Bile acid profiling as an effective biomarker for staging in pediatric inflammatory bowel disease. Gut Microbes. 2024;16(1):2323231.","journal-title":"Gut Microbes"},{"key":"4353_CR7","doi-asserted-by":"publisher","first-page":"100465","DOI":"10.1016\/j.eclinm.2020.100465","volume":"25","author":"MG Shiha","year":"2020","unstructured":"Shiha MG, Ashgar Z, Fraser EM, Kurien M, Aziz I. High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria. EClinicalMedicine. 2020;25:100465.","journal-title":"EClinicalMedicine."},{"issue":"10","key":"4353_CR8","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.14309\/ajg.0000000000002859","volume":"119","author":"AM Ellegaard","year":"2024","unstructured":"Ellegaard AM, K\u00e5rhus ML, Winther-Jensen M, Knop FK, K\u00e5rhus LL. Bile Acid Diarrhea Is Associated With an Increased Incidence of Gastrointestinal Cancers. Am J Gastroenterol. 2024;119(10):2107\u201313.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"4353_CR9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.14309\/ajg.0000000000002886","volume":"119","author":"J Tome","year":"2024","unstructured":"Tome J, Tariq R, Chelf CJ, Khanna S, Pardi DS. Effectiveness of Bile Acid Sequestrants in Microscopic Colitis and Utility of Bile Acid Testing: A Systematic Review and Meta-analysis. Am J Gastroenterol. 2024;119(9):1792\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"4353_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJM196908212810801","volume":"281","author":"AF Hofmann","year":"1969","unstructured":"Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med. 1969;281(8):397\u2013402.","journal-title":"N Engl J Med"},{"issue":"8","key":"4353_CR11","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/apt.13570","volume":"43","author":"N Mottacki","year":"2016","unstructured":"Mottacki N, Simr\u00e9n M, Bajor A. Review article: bile acid diarrhoea - pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2016;43(8):884\u201398.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"4353_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7861\/clinmedicine.10-2-124","volume":"10","author":"U Khalid","year":"2010","unstructured":"Khalid U, Lalji A, Stafferton R, Andreyev J. Bile acid malabsoption: a forgotten diagnosis? Clin Med (Lond). 2010;10(2):124\u20136.","journal-title":"Clin Med (Lond)"},{"issue":"12","key":"4353_CR13","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.14309\/ajg.0000000000000962","volume":"115","author":"JRF Walters","year":"2020","unstructured":"Walters JRF. Making the Diagnosis of Bile Acid Diarrhea. Am J Gastroenterol. 2020;115(12):1974\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"4353_CR14","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.cgh.2018.11.012","volume":"17","author":"R Battat","year":"2019","unstructured":"Battat R, Duijvestein M, Vande Casteele N, Singh S, Dulai PS, Valasek MA, et al. Serum Concentrations of 7\u03b1-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn\u2019s Disease. Clin Gastroenterol Hepatol. 2019;17(13):2722-2730.e2724.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"4353_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1023\/A:1026681512303","volume":"44","author":"GH Sauter","year":"1999","unstructured":"Sauter GH, M\u00fcnzing W, von Ritter C, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci. 1999;44(1):14\u20139.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"4353_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/ibd.21502","volume":"17","author":"M Lenicek","year":"2011","unstructured":"Lenicek M, Duricova D, Komarek V, Gabrysova B, Lukas M, Smerhovsky Z, et al. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm Bowel Dis. 2011;17(6):1322\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"4353_CR17","doi-asserted-by":"crossref","unstructured":"Black CJ, Olano C, Quigley EMM, Ford AC. Common misconceptions and controversies in the management of irritable bowel syndrome. Nat Rev Gastroenterol Hepatol. 2025;22(7):517\u201326.","DOI":"10.1038\/s41575-025-01065-9"},{"issue":"4","key":"4353_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00042737-200604000-00013","volume":"18","author":"A Bajor","year":"2006","unstructured":"Bajor A, Kilander A, Fae A, G\u00e4lman C, Jonsson O, Ohman L, et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol. 2006;18(4):397\u2013403.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"4353_CR19","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1136\/gutjnl-2015-309889","volume":"65","author":"N Valentin","year":"2016","unstructured":"Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut. 2016;65(12):1951\u20139.","journal-title":"Gut"},{"issue":"10","key":"4353_CR20","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/s44321-024-00129-8","volume":"16","author":"X Li","year":"2024","unstructured":"Li X, Hu S, Shen X, Zhang R, Liu C, Xiao L, et al. Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn\u2019s disease. EMBO Mol Med. 2024;16(10):2427\u201349.","journal-title":"EMBO Mol Med"},{"issue":"10","key":"4353_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/apt.13594","volume":"43","author":"DC Baumgart","year":"2016","unstructured":"Baumgart DC, Bokemeyer B, Drabik A, Stallmach A, Schreiber S. Vedolizumab induction therapy for inflammatory bowel disease in clinical practice\u2013a nationwide consecutive German cohort study. Aliment Pharmacol Ther. 2016;43(10):1090\u2013102.","journal-title":"Aliment Pharmacol Ther"},{"key":"4353_CR22","doi-asserted-by":"crossref","unstructured":"Fecal Microbiota Transplantation-standardization Study Group. Nanjing consensus on methodology of washed microbiota transplantation. Chin Med J (Engl). 2020;133(19):2330\u20132.","DOI":"10.1097\/CM9.0000000000000954"},{"key":"4353_CR23","doi-asserted-by":"crossref","unstructured":"Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, et al. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020;11(4):251\u2013266.","DOI":"10.1007\/s13238-019-00684-8"},{"issue":"9","key":"4353_CR24","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/1751-7915.14074","volume":"15","author":"G Lu","year":"2022","unstructured":"Lu G, Wang W, Li P, Wen Q, Cui B, Zhang F. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol. 2022;15(9):2439\u201349.","journal-title":"Microb Biotechnol"},{"issue":"6487","key":"4353_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.aau6481","volume":"368","author":"NJ Bessman","year":"2020","unstructured":"Bessman NJ, Mathieu JRR, Renassia C, Zhou L, Fung TC, Fernandez KC, et al. Dendritic cell\u2013derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science. 2020;368(6487):186\u20139.","journal-title":"Science"},{"issue":"9","key":"4353_CR26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.stem.2022.08.008","volume":"29","author":"L Chen","year":"2022","unstructured":"Chen L, Jiao T, Liu W, Luo Y, Wang J, Guo X, et al. Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. Cell Stem Cell. 2022;29(9):1366-1381.e1369.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"4353_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060\u201383.","journal-title":"Nat Protoc"},{"issue":"2","key":"4353_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/flgastro-2017-100808","volume":"9","author":"M Kurien","year":"2018","unstructured":"Kurien M, Thurgar E, Davies A, Akehurst R, Andreyev J. Challenging current views on bile acid diarrhoea and malabsorption. Frontline Gastroenterol. 2018;9(2):92\u20137.","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"4353_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00253-018-9447-x","volume":"103","author":"P Li","year":"2019","unstructured":"Li P, Zhang T, Xiao Y, Tian L, Cui B, Ji G, et al. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn\u2019s disease. Appl Microbiol Biotechnol. 2019;103(1):349\u201360.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"4353_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814\u201321.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"4353_CR31","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685\u20138.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4353_CR32","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/19490976.2020.1747329","volume":"11","author":"Z Dan","year":"2020","unstructured":"Dan Z, Mao X, Liu Q, Guo M, Zhuang Y, Liu Z, et al. Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder. Gut Microbes. 2020;11(5):1246\u201367.","journal-title":"Gut Microbes"},{"issue":"6","key":"4353_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1155\/2011\/701287","volume":"25","author":"WG Brydon","year":"2011","unstructured":"Brydon WG, Culbert P, Kingstone K, Jarvie A, Iacucci M, Tenhage M, et al. An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can J Gastroenterol. 2011;25(6):319\u201323.","journal-title":"Can J Gastroenterol"},{"issue":"7","key":"4353_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2982.2009.01288.x","volume":"21","author":"M Camilleri","year":"2009","unstructured":"Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009;21(7):734-e743.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"4353_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7(2):141\u201351.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"4353_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","volume":"3","author":"PH Johnsen","year":"2018","unstructured":"Johnsen PH, Hilp\u00fcsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17\u201324.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"4353_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13054-019-2604-5","volume":"23","author":"M Dai","year":"2019","unstructured":"Dai M, Liu Y, Chen W, Buch H, Shan Y, Chang L, Bai Y, Shen C, Zhang X, Huo Y, et al. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients. Crit Care. 2019;23(1):324.","journal-title":"Crit Care"},{"issue":"1","key":"4353_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/gutjnl-2021-325010","volume":"71","author":"J Bili\u0144ski","year":"2022","unstructured":"Bili\u0144ski J, Winter K, Jasi\u0144ski M, Szcz\u0119\u015b A, Bilinska N, Mullish BH, et al. Rapid resolution of COVID-19 after faecal microbiota transplantation. Gut. 2022;71(1):230\u20132.","journal-title":"Gut"},{"issue":"1","key":"4353_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gutjnl-2020-322630","volume":"70","author":"P de Groot","year":"2021","unstructured":"de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021;70(1):92\u2013105.","journal-title":"Gut"},{"issue":"7","key":"4353_CR40","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","volume":"115","author":"L Craven","year":"2020","unstructured":"Craven L, Rahman A, Nair Parvathy S, Beaton M, Silverman J, Qumosani K, et al. Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. Am J Gastroenterol. 2020;115(7):1055\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"4353_CR41","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/hep.31496","volume":"73","author":"JS Bajaj","year":"2021","unstructured":"Bajaj JS, Gavis EA, Fagan A, Wade JB, Thacker LR, Fuchs M, et al. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder. Hepatology. 2021;73(5):1688\u2013700.","journal-title":"Hepatology"},{"issue":"6529","key":"4353_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science. 2021;371(6529):595\u2013602.","journal-title":"Science"},{"key":"4353_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.radonc.2020.01.011","volume":"143","author":"X Ding","year":"2020","unstructured":"Ding X, Li Q, Li P, Chen X, Xiang L, Bi L, et al. Fecal microbiota transplantation: A promising treatment for radiation enteritis? Radiother Oncol. 2020;143:12\u20138.","journal-title":"Radiother Oncol"},{"issue":"16","key":"4353_CR44","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","volume":"128","author":"K Kakihana","year":"2016","unstructured":"Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood. 2016;128(16):2083\u20138.","journal-title":"Blood"},{"key":"4353_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2021.06.022","volume":"233","author":"A Watane","year":"2022","unstructured":"Watane A, Cavuoto KM, Rojas M, Dermer H, Day JO, Banerjee S, et al. Fecal Microbial Transplant in Individuals With Immune-Mediated Dry Eye. Am J Ophthalmol. 2022;233:90\u2013100.","journal-title":"Am J Ophthalmol"},{"key":"4353_CR46","unstructured":"GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221\u201348."},{"issue":"5","key":"4353_CR47","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2017.04.027","volume":"169","author":"F Lebreton","year":"2017","unstructured":"Lebreton F, Manson AL, Saavedra JT, Straub TJ, Earl AM, Gilmore MS. Tracing the Enterococci from Paleozoic Origins to the Hospital. Cell. 2017;169(5):849-861.e813.","journal-title":"Cell"},{"issue":"4","key":"4353_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.chom.2016.09.004","volume":"20","author":"D Keogh","year":"2016","unstructured":"Keogh D, Tay WH, Ho YY, Dale JL, Chen S, Umashankar S, et al. Enterococcal Metabolite Cues Facilitate Interspecies Niche Modulation and Polymicrobial Infection. Cell Host Microbe. 2016;20(4):493\u2013503.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"4353_CR49","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/antibiotics12081311","volume":"12","author":"JC Plata","year":"2023","unstructured":"Plata JC, D\u00edaz-B\u00e1ez D, Delgadillo NA, Castillo DM, Castillo Y, Hurtado CP, et al. Hypochlorous Acid as a Potential Postsurgical Antimicrobial Agent in Periodontitis: A Randomized, Controlled, Non-Inferiority Trial. Antibiotics (Basel). 2023;12(8):1311.","journal-title":"Antibiotics (Basel)."},{"key":"4353_CR50","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez Vecilla D, Roche Matheus MP, Urrutikoetxea Guti\u00e9rrez M, Iglesias Hidalgo G, Aspichueta Vivanco C, D\u00edaz de Tuesta Del Arco JL. Brain abscess caused by Porphyromonas gingivalis and Eubacterium nodatum mimicking acute stroke. Anaerobe. 2023;84:102801.","DOI":"10.1016\/j.anaerobe.2023.102801"},{"issue":"11","key":"4353_CR51","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0003-9969(94)90080-9","volume":"39","author":"MA Hamid","year":"1994","unstructured":"Hamid MA, Iwaku M, Hoshino E. The metabolism of phenylalanine and leucine by a cell suspension of Eubacterium brachy and the effects of metronidazole on metabolism. Arch Oral Biol. 1994;39(11):967\u201372.","journal-title":"Arch Oral Biol"},{"issue":"4","key":"4353_CR52","first-page":"519","volume":"16","author":"Y Ma","year":"2021","unstructured":"Ma Y, Xin M, Wen Y, Wang H, Zhang G, Dai J, et al. The utility of endogenous glycochenodeoxycholate-3-sulfate and 4\u03b2-hydroxycholesterol to evaluate the hepatic disposition of atorvastatin in rats. Asian J Pharm Sci. 2021;16(4):519\u201329.","journal-title":"Asian J Pharm Sci"},{"key":"4353_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.153927","volume":"97","author":"Q Xie","year":"2022","unstructured":"Xie Q, Li H, Ma R, Ren M, Li Y, Li J, et al. Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model. Phytomedicine. 2022;97: 153927.","journal-title":"Phytomedicine"},{"issue":"4","key":"4353_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62(4):531\u20139.","journal-title":"Gut"},{"issue":"7785","key":"4353_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576(7785):143\u20138.","journal-title":"Nature"},{"issue":"3","key":"4353_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.kint.2023.03.024","volume":"104","author":"S Gharaie","year":"2023","unstructured":"Gharaie S, Lee K, Newman-Rivera AM, Xu J, Patel SK, Gooya M, et al. Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosis. Kidney Int. 2023;104(3):470\u201391.","journal-title":"Kidney Int"},{"key":"4353_CR57","doi-asserted-by":"crossref","unstructured":"Ding Y, Luo X, Guo J, Xing B, Lin H, Ma H, et al. Identification of gut microbial bile acid metabolic enzymes via an AI-assisted pipeline. Cell. 2025;S0092\u20138674(25)00806\u20132.","DOI":"10.1016\/j.cell.2025.07.017"},{"issue":"4","key":"4353_CR58","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong J, Liu P, Han Z, Ying W, Li C, Yang Y, et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions. Immunity. 2024;57(4):876-889.e11.","journal-title":"Immunity"},{"issue":"4","key":"4353_CR59","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33(4):791-803.e797.","journal-title":"Cell Metab"},{"key":"4353_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102766","volume":"55","author":"M Wei","year":"2020","unstructured":"Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. 2020;55: 102766.","journal-title":"EBioMedicine"},{"key":"4353_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105265","volume":"106","author":"A Wahlstr\u00f6m","year":"2024","unstructured":"Wahlstr\u00f6m A, Aydin \u00d6, Olsson LM, Sj\u00f6land W, Henricsson M, Lundqvist A, et al. Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes. EBioMedicine. 2024;106: 105265.","journal-title":"EBioMedicine"},{"issue":"12","key":"4353_CR62","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018;24(12):1919\u201329.","journal-title":"Nat Med"},{"issue":"493","key":"4353_CR63","doi-asserted-by":"publisher","first-page":"eaal5241","DOI":"10.1126\/scisignal.aal5241","volume":"10","author":"CE Ramsden","year":"2017","unstructured":"Ramsden CE, Domenichiello AF, Yuan ZX, Sapio MR, Keyes GS, Mishra SK, et al. A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch. Sci Signal. 2017;10(493):eaal5241.","journal-title":"Sci Signal."},{"issue":"1","key":"4353_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9\u201329.","journal-title":"Nat Rev Neurol"},{"key":"4353_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2019.12.010","volume":"293","author":"G Charach","year":"2020","unstructured":"Charach G, Karniel E, Novikov I, Galin L, Vons S, Grosskopf I, et al. Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study. Atherosclerosis. 2020;293:79\u201385.","journal-title":"Atherosclerosis"},{"key":"4353_CR66","doi-asserted-by":"crossref","unstructured":"Sleutjes JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC. Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation. Inflamm Bowel Dis. 2023;29(4):531\u20138.","DOI":"10.1093\/ibd\/izac100"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:21:06Z","timestamp":1756898466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04353-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. It was a part of two registered trials (ClinicalTrials.gov: NCT01790061 and NCT01793831) and approved by the Second Affiliated Hospital of Nanjing Medical University Institutional Ethical Review Board. Written informed consents to participate in this study were provided by patients or their legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents for publication were provided by patients or their legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Faming Zhang holds patents on an automatic purification system and transendoscopic enteral tubing and devices related to them. The remaining authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"511"}}